Setting the stage for risk-sharing agreements: International experiences and outcomes-based reimbursement
Background: Biological medicines are clinically effective but very expensive in South Africa. The business decisions of biological manufacturers and payers (medical schemes) impact the access patient's have to biological medicines. This paper presents risk-sharing agreements as a means of manag...
Saved in:
| Main Author: | Joao L. Carapinha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2008-08-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/1052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Policy guidelines for risk-sharing agreements in South Africa
by: Joao L. Carapinha
Published: (2008-10-01) -
PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION
by: L. S. Melnikova
Published: (2015-06-01) -
Getting Ours? “Girlbossing” and the Ethics of Nurse Reimbursement Models
by: Danisha Jenkins, et al.
Published: (2024-12-01) -
Formation of income amount of builder in share building under mixed agreement
by: S.A. Yestchenko
Published: (2016-07-01) -
Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
by: Zoltán Kaló, et al.
Published: (2017-01-01)